These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 12730669)
1. Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis. Wang QF; Cleaves R; Kummalue T; Nerlov C; Friedman AD Oncogene; 2003 May; 22(17):2548-57. PubMed ID: 12730669 [TBL] [Abstract][Full Text] [Related]
2. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding. Cleaves R; Wang QF; Friedman AD Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106 [TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192 [TBL] [Abstract][Full Text] [Related]
4. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha. Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649 [TBL] [Abstract][Full Text] [Related]
5. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene. Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245 [TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476 [TBL] [Abstract][Full Text] [Related]
7. The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo. Porse BT; Pedersen TA; Hasemann MS; Schuster MB; Kirstetter P; Luedde T; Damgaard I; Kurz E; Schjerling CK; Nerlov C Mol Cell Biol; 2006 Feb; 26(3):1028-37. PubMed ID: 16428455 [TBL] [Abstract][Full Text] [Related]
8. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500 [TBL] [Abstract][Full Text] [Related]
9. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction. Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022 [TBL] [Abstract][Full Text] [Related]
10. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells. Shimokawa T; Nunomura S; Fujisawa D; Ra C Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158 [TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor. Wang QF; Friedman AD Blood; 2002 Apr; 99(8):2776-85. PubMed ID: 11929766 [TBL] [Abstract][Full Text] [Related]
13. Functional interaction of CCAAT/enhancer-binding-protein-α basic region mutants with E2F transcription factors and DNA. Kowenz-Leutz E; Schuetz A; Liu Q; Knoblich M; Heinemann U; Leutz A Biochim Biophys Acta; 2016 Jul; 1859(7):841-7. PubMed ID: 27131901 [TBL] [Abstract][Full Text] [Related]
14. Reciprocal effects of C/EBPalpha and PKCdelta on JunB expression and monocytic differentiation depend upon the C/EBPalpha basic region. Liu H; Keefer JR; Wang QF; Friedman AD Blood; 2003 May; 101(10):3885-92. PubMed ID: 12522006 [TBL] [Abstract][Full Text] [Related]
15. Runx1, c-Myb, and C/EBPalpha couple differentiation to proliferation or growth arrest during hematopoiesis. Friedman AD J Cell Biochem; 2002; 86(4):624-9. PubMed ID: 12210729 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of granulocyte and monocyte development. Friedman AD Oncogene; 2002 May; 21(21):3377-90. PubMed ID: 12032776 [TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022 [TBL] [Abstract][Full Text] [Related]
18. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription. Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211 [TBL] [Abstract][Full Text] [Related]
20. Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. Salma N; Xiao H; Imbalzano AN J Mol Endocrinol; 2006 Feb; 36(1):139-51. PubMed ID: 16461934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]